Table 1.
Descriptive statistics of variables in the sample.
All participants | n = 196 |
Male | n = 151 |
Female | n = 45 |
Age in years | |
Average ± SD | 63.13 ± 10.99 |
Median | 61 |
Values of histopathological variables | |
Grade 1 | 66 (33.7%) |
Grade 2 | 95 (48.5%) |
Grade 3 | 31 (15.8%) |
Grade 4 | 4 (2%) |
Extranodal extension | 45 (22.9%) |
Angioinvasion | 31 (15.8%) |
Perineural invasion | 91 (46.4%) |
Average tumor stroma ratio | 39.6 |
Tumor budding | |
Grade I (<5) | 130 (66.3%) |
Grade II (>5) | 66 (33.7%) |
Combined score | |
Low risk | 85 (43.4%) |
Intermediate risk | 74 (37.8%) |
High risk | 37 (18.9%) |
Average depth of tumor invasion (mm) | 15.09 |
Average tumor diameter (mm) | 32.1 |
Number of patients with metastatic disease at the start of treatment | 93 (47.4%) |
Number of patients with the occurrence of metastatic disease during follow-up | 49 (25%) |
TNM categories | |
pT1 | 15 (7.6%) |
pT2 | 55 (28.1%) |
pT3 | 41 (20.9%) |
pT4 | 85 (43.4%) |
N0 | 103 (55.6%) |
N1 | 23 (11.7%) |
N2 | 35 (17.9%) |
N3 | 35 (17.9%) |
Localization | |
Retromolar | 37 (18.9%) |
Manidibular gingiva | 49 (25%) |
Sublingual | 59 (30.1%) |
Tongue | 29 (14.8%) |
Maxillary gingiva | 9 (4.6%) |
Hard palate | 13 (6.6%) |
Average follow-up in months | 44.9 |